United Therapeutics (UTHR) Tops Q1 EPS by 10c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $544.33 +1.12%
EPS Growth %: +12.6%
Financial Fact:
Operating income: 238.6M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +12.6%
Financial Fact:
Operating income: 238.6M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $6.63, $0.10 better than the analyst estimate of $6.53. Revenue for the quarter came in at $794.4 million versus the consensus estimate of $728.34 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- After-Hours Stock Movers: FDX, CBRS, NKE
- Cerebras Systems posts 94% revenue jump, announces OpenAI deal
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
